Shares of British pharmaceutical giant GSK surged on Wednesday after the company raised its long-term sales forecast and ...
Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, ...
Strong full-year trading and an improving outlook have propelled GSK's share price higher, as Royston Wild explains.
On Monday, GSK plc (GSK) stock saw a decline, ending the day at $34.9 which represents a decrease of $-0.37 or -1.05% from the prior close of $35.27. The stock opened at $34.87 and touched a low of ...
European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.
Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.
GSK PLC closed 24.32% short of its 52-week high of £18.24, which the company achieved on May 16th.
GSK was forced to pay around £1.8bn to settle thousands of cases in US courts in October amid claims Zantac caused cancer.
Bearish flow noted in GSK (GSK) Pharma with 1,131 puts trading, or 2x expected. Most active are Mar-25 33 puts and Jan-26 35 puts, with total volume in those strikes near 730 contracts. The Put/Call ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback